Irish Skin Foundation Psoriasis
5 talks | 1 hour 28 min | General Practice
My name is Eoin O’Brien and as chairman of the Irish Skin Foundation I am pleased to introduce this educational project on psoriasis. The Irish Skin Foundation is a new organisation which was founded in 2011 and its mission is to support patients with all forms of skin disease. In this regard it is somewhat unique. There are many organisations in Europe that support one form of skin disease or another but none that advocate for all patients with all forms of skin disease.
Modern science has revolutionised the treatment of skin disease and continues to do so. The Irish Skin Foundation has a unique association with the Charles Institute in University College Dublin. And through this unique association we hope to be able to bring the best treatment for skin disease from the bench to the bedside. This is often called translational medicine.
The Irish Skin Foundation is reaching to all people involved in the management of patients with skin disease, nurses, specialists, pharmacists and most importantly general practitioners and their patients. We propose to do that by providing information which will be freely available to patients but also support to anybody who is managing patients with skin disease and in that regard we link very closely with general practice.
In this regard the Irish Skin Foundation will be relying on your support, not alone to supporters in joining in whatever research we may be doing into skin disease but also lending us your support in a financial sense and you can do this by becoming a friend of the Irish Skin Foundation by simply contacting our website www.irishskinfoundation.ie.
In closing it gives me great pleasure to introduce this project and to thank AbbVie for its educational support.
|Speakers:||Dr Anne-Marie Tobin, Dr Kate Russo, Carmel Blake, Dr Mark Wheeler, Sheila Ryan|
|Meeting Location:||Virtual Meeting|
|Online Publication Date:|
|Professional Competency Credits:||1 hour 28 min|
|Approved for CPD:||ICGP|
This meeting was sponsored by an unrestricted educational grant from Abbvie Ltd.